Brent L. Larson

2013

In 2013, Brent L. Larson earned a total compensation of $593K as Executive Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$51,013
Option Awards$260,387
Salary$274,717
Other$6,847
Total$592,964

Larson received $274.7K in salary, accounting for 46% of the total pay in 2013.

Larson also received $51K in non-equity incentive plan, $260.4K in option awards and $6.8K in other compensation.

Rankings

In 2013, Brent L. Larson's compensation ranked 8,759th out of 12,286 executives tracked by ExecPay. In other words, Larson earned more than 28.7% of executives.

ClassificationRankingPercentile
All
8,759
out of 12,286
29th
Division
Manufacturing
3,190
out of 4,612
31st
Major group
Chemicals And Allied Products
1,012
out of 1,462
31st
Industry group
Drugs
771
out of 1,156
33rd
Industry
In Vitro and In Vivo Diagnostic Substances
33
out of 56
41st
Source: SEC filing on July 1, 2016.

Larson's colleagues

We found four more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2013.

2013

Mark Pykett

Navidea Biopharmaceuticals

Chief Executive Officer

2013

Thomas Tulip

Navidea Biopharmaceuticals

President and Chief Business Officer

2013

Cornelia Reininger

Navidea Biopharmaceuticals

Chief Medical Officer

2013

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

You may also like